drugset / Trial / NCT06697184
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to establish the safety of novel dosing and ramp-up schedules for sonrotoclax in participants with hematological malignancies.
Timeline
- Start
- 2025-01-23
- Primary completion
- 2029-11-30
- Completion
- 2032-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sonrotoclax | Other / unclassified | — | Oral |
| Background | Zanubrutinib | Small molecule | — | Oral |